Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
Outrun TX has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Outrun TX's investors include M Ventures, MP Healthcare Venture Management.
Outrun TX is headquartered in Dundee, United Kingdom.
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
Outrun TX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Outrun TX — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/outrun-tx. Accessed August 14, 2026.
VCBacked. (2024). Outrun TX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/outrun-tx
{{cite web |title=Outrun TX — Funding & Investors |url=https://www.vcbacked.co/company/outrun-tx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated